References
- Roxburgh CS, McMillan DC. The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer. Cancer Treat Rev 2012; 38:451 - 66; http://dx.doi.org/10.1016/j.ctrv.2011.09.001; PMID: 21945823
- Klintrup K, Mäkinen JM, Kauppila S, Väre PO, Melkko J, Tuominen H, Tuppurainen K, Mäkelä J, Karttunen TJ, Mäkinen MJ. Inflammation and prognosis in colorectal cancer. Eur J Cancer 2005; 41:2645 - 54; http://dx.doi.org/10.1016/j.ejca.2005.07.017; PMID: 16239109
- Väyrynen JP, Tuomisto A, Klintrup K, Mäkelä J, Karttunen TJ, Mäkinen MJ. Detailed analysis of inflammatory cell infiltration in colorectal cancer. Br J Cancer 2013; 109:1839 - 47; http://dx.doi.org/10.1038/bjc.2013.508; PMID: 24008661
- Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. Cell 2010; 141:39 - 51; http://dx.doi.org/10.1016/j.cell.2010.03.014; PMID: 20371344
- Roxburgh CS, McMillan DC. . Cancer, Immunity and Inflammation. Oxford Textbook of Oncology.2014; In press
- Marik PE, Flemmer M. The immune response to surgery and trauma: Implications for treatment. J Trauma Acute Care Surg 2012; 73:801 - 8; http://dx.doi.org/10.1097/TA.0b013e318265cf87; PMID: 22976420
- Roxburgh CS, McMillan DC. Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Future Oncol 2010; 6:149 - 63; http://dx.doi.org/10.2217/fon.09.136; PMID: 20021215
- McArdle CS, McMillan DC, Hole DJ. Impact of anastomotic leakage on long-term survival of patients undergoing curative resection for colorectal cancer. Br J Surg 2005; 92:1150 - 4; http://dx.doi.org/10.1002/bjs.5054; PMID: 16035134
- Richards CH, Platt JJ, Anderson JH, McKee RF, Horgan PG, McMillan DC. The impact of perioperative risk, tumor pathology and surgical complications on disease recurrence following potentially curative resection of colorectal cancer. Ann Surg 2011; 254:83 - 9; http://dx.doi.org/10.1097/SLA.0b013e31821fd469; PMID: 21572320
- Forget P, Machiels JP, Coulie PG, Berliere M, Poncelet AJ, Tombal B, Stainier A, Legrand C, Canon JL, Kremer Y, et al. Neutrophil:Lymphocyte Ratio and Intraoperative Use of Ketorolac or Diclofenac are Prognostic Factors in Different Cohorts of Patients Undergoing Breast, Lung, and Kidney Cancer Surgery. [Epub ahead of print] Ann Surg Oncol 2013; http://dx.doi.org/10.1245/s10434-013-3136-x; PMID: 23884751